 treatment metastat melanoma autolog tumor-cel vaccin clinic immunolog result patient patient metastat melanoma melanoma vaccin low-dos cyclophosphamid CY immunolog effect antitumor activ day patient CY day vaccin consist autolog Gy tumor cell mix bacillu calmette-guerin bcg treatment sequenc day assess patient measur metastas respons complet partial median durat month month addit patient antitumor respons peculiar vaccin therapi regress metastat lesion immunotherapi delayed-typ hypersensit dth autolog dissoci melanoma cell extran antigen enzym fetal calf serum immunotherapi day day day day day day respons vaccin dth observ patient tumor regress posit dth postsurg adjuv patient signific linear relationship intens dth autolog melanoma cell time recurr tumor patient dth autolog melanoma cell origin vaccin new metastas dth respons case abl tumor histolog examin tumor intens infiltr lymphocyt demonstr immun respons melanoma-associ antigen cancer-bear patient basi optim prospect activ immunotherapi practic therapeut valu